Literature DB >> 24011578

Epigenetics of progression of chronic kidney disease: fact or fantasy?

Maria R Wing1, Ali Ramezani, Harindarpal S Gill, Joseph M Devaney, Dominic S Raj.   

Abstract

Epigenetic modifications are important in the normal functioning of the cell, from regulating dynamic expression of essential genes and associated proteins to repressing those that are unneeded. Epigenetic changes are essential for development and functioning of the kidney, and aberrant methylation, histone modifications, and expression of microRNA could lead to chronic kidney disease (CKD). Here, epigenetic modifications modulate transforming growth factor β signaling, inflammation, profibrotic genes, and the epithelial-to-mesenchymal transition, promoting renal fibrosis and progression of CKD. Identification of these epigenetic changes is important because they are potentially reversible and may serve as therapeutic targets in the future to prevent subsequent renal fibrosis and CKD. In this review we discuss the different types of epigenetic control, methods to study epigenetic modifications, and how epigenetics promotes progression of CKD.
© 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  DNA methylation; EMT; chronic kidney disease (CKD); microRNAs; renal fibrosis

Mesh:

Substances:

Year:  2013        PMID: 24011578      PMCID: PMC3885870          DOI: 10.1016/j.semnephrol.2013.05.008

Source DB:  PubMed          Journal:  Semin Nephrol        ISSN: 0270-9295            Impact factor:   5.299


  103 in total

1.  Methylation meets genomics.

Authors:  A P Feinberg
Journal:  Nat Genet       Date:  2001-01       Impact factor: 38.330

2.  Variation, patterns, and temporal stability of DNA methylation: considerations for epigenetic epidemiology.

Authors:  Rudolf P Talens; Dorret I Boomsma; Elmar W Tobi; Dennis Kremer; J Wouter Jukema; Gonneke Willemsen; Hein Putter; P Eline Slagboom; Bastiaan T Heijmans
Journal:  FASEB J       Date:  2010-04-12       Impact factor: 5.191

Review 3.  Nature and nurture - lessons from chemical carcinogenesis.

Authors:  Andreas Luch
Journal:  Nat Rev Cancer       Date:  2005-02       Impact factor: 60.716

Review 4.  Epigenetic control in the immune response.

Authors:  Steven L Reiner
Journal:  Hum Mol Genet       Date:  2005-04-15       Impact factor: 6.150

5.  Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans.

Authors:  A Fire; S Xu; M K Montgomery; S A Kostas; S E Driver; C C Mello
Journal:  Nature       Date:  1998-02-19       Impact factor: 49.962

6.  Angiotensin II-mediated Nrf2 down-regulation: a potential causing factor for renal fibrosis?

Authors:  Keon Wook Kang
Journal:  Arch Pharm Res       Date:  2011-05       Impact factor: 4.946

7.  DNA methylation: bisulphite modification and analysis.

Authors:  Susan J Clark; Aaron Statham; Clare Stirzaker; Peter L Molloy; Marianne Frommer
Journal:  Nat Protoc       Date:  2006       Impact factor: 13.491

8.  Genome-wide analysis of epigenetic signatures for kidney-specific transporters.

Authors:  Ryota Kikuchi; Shintaro Yagi; Hiroyuki Kusuhara; Satoki Imai; Yuichi Sugiyama; Kunio Shiota
Journal:  Kidney Int       Date:  2010-06-16       Impact factor: 10.612

9.  Immunologic function and survival in hemodialysis patients.

Authors:  P L Kimmel; T M Phillips; S J Simmens; R A Peterson; K L Weihs; S Alleyne; I Cruz; J A Yanovski; J H Veis
Journal:  Kidney Int       Date:  1998-07       Impact factor: 10.612

10.  Suppression of Klotho expression by protein-bound uremic toxins is associated with increased DNA methyltransferase expression and DNA hypermethylation.

Authors:  Chiao-Yin Sun; Shih-Chung Chang; Mai-Szu Wu
Journal:  Kidney Int       Date:  2012-01-11       Impact factor: 10.612

View more
  33 in total

1.  Klotho recovery by genistein via promoter histone acetylation and DNA demethylation mitigates renal fibrosis in mice.

Authors:  Yanning Li; Fang Chen; Ai Wei; Fangfang Bi; Xiaobo Zhu; Shasha Yin; Wenjun Lin; Wangsen Cao
Journal:  J Mol Med (Berl)       Date:  2019-02-26       Impact factor: 4.599

Review 2.  Mechanisms of maladaptive repair after AKI leading to accelerated kidney ageing and CKD.

Authors:  David A Ferenbach; Joseph V Bonventre
Journal:  Nat Rev Nephrol       Date:  2015-02-03       Impact factor: 28.314

Review 3.  The role of epigenetics in renal ageing.

Authors:  Paul G Shiels; Dagmara McGuinness; Maria Eriksson; Jeroen P Kooman; Peter Stenvinkel
Journal:  Nat Rev Nephrol       Date:  2017-06-19       Impact factor: 28.314

4.  Progression after AKI: Understanding Maladaptive Repair Processes to Predict and Identify Therapeutic Treatments.

Authors:  David P Basile; Joseph V Bonventre; Ravindra Mehta; Masaomi Nangaku; Robert Unwin; Mitchell H Rosner; John A Kellum; Claudio Ronco
Journal:  J Am Soc Nephrol       Date:  2015-10-30       Impact factor: 10.121

5.  Circulating and urinary microRNA profile in focal segmental glomerulosclerosis: a pilot study.

Authors:  Ali Ramezani; Joseph M Devaney; Scott Cohen; Maria R Wing; Richard Scott; Susan Knoblach; Rishi Singhal; Lilian Howard; Jeffrey B Kopp; Dominic S Raj
Journal:  Eur J Clin Invest       Date:  2015-04       Impact factor: 4.686

Review 6.  Epigenetics in Kidney Transplantation: Current Evidence, Predictions, and Future Research Directions.

Authors:  Valeria R Mas; Thu H Le; Daniel G Maluf
Journal:  Transplantation       Date:  2016-01       Impact factor: 4.939

Review 7.  Acute kidney injury and chronic kidney disease: From the laboratory to the clinic.

Authors:  David A Ferenbach; Joseph V Bonventre
Journal:  Nephrol Ther       Date:  2016-03-10       Impact factor: 0.722

8.  DNA hypermethylation in hyperhomocysteinemia contributes to abnormal extracellular matrix metabolism in the kidney.

Authors:  Sathnur Pushpakumar; Sourav Kundu; Nithya Narayanan; Utpal Sen
Journal:  FASEB J       Date:  2015-07-29       Impact factor: 5.191

Review 9.  Genetic Considerations in Pediatric Chronic Kidney Disease.

Authors:  Lyndsay A Harshman; Diana Zepeda-Orozco
Journal:  J Pediatr Genet       Date:  2015-08-13

10.  Targeting histone methyltransferase enhancer of zeste homolog-2 inhibits renal epithelial-mesenchymal transition and attenuates renal fibrosis.

Authors:  Xiaoxu Zhou; Chongxiang Xiong; Evelyn Tolbert; Ting C Zhao; George Bayliss; Shougang Zhuang
Journal:  FASEB J       Date:  2018-05-18       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.